834 related articles for article (PubMed ID: 25787076)
1. Inhibition of Stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system, leading to preservation of muscle mass in cancer cachexia.
Silva KA; Dong J; Dong Y; Dong Y; Schor N; Tweardy DJ; Zhang L; Mitch WE
J Biol Chem; 2015 Apr; 290(17):11177-87. PubMed ID: 25787076
[TBL] [Abstract][Full Text] [Related]
2. Cryptotanshinone prevents muscle wasting in CT26-induced cancer cachexia through inhibiting STAT3 signaling pathway.
Chen L; Yang Q; Zhang H; Wan L; Xin B; Cao Y; Zhang J; Guo C
J Ethnopharmacol; 2020 Oct; 260():113066. PubMed ID: 32505837
[TBL] [Abstract][Full Text] [Related]
3. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H
Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy.
Reed SA; Sandesara PB; Senf SM; Judge AR
FASEB J; 2012 Mar; 26(3):987-1000. PubMed ID: 22102632
[TBL] [Abstract][Full Text] [Related]
5. Muscle-specific E3 ubiquitin ligases are involved in muscle atrophy of cancer cachexia: an in vitro and in vivo study.
Yuan L; Han J; Meng Q; Xi Q; Zhuang Q; Jiang Y; Han Y; Zhang B; Fang J; Wu G
Oncol Rep; 2015 May; 33(5):2261-8. PubMed ID: 25760630
[TBL] [Abstract][Full Text] [Related]
6. C/EBPβ mediates tumour-induced ubiquitin ligase atrogin1/MAFbx upregulation and muscle wasting.
Zhang G; Jin B; Li YP
EMBO J; 2011 Aug; 30(20):4323-35. PubMed ID: 21847090
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms involved in 3',5'-cyclic adenosine monophosphate-mediated inhibition of the ubiquitin-proteasome system in skeletal muscle.
Gonçalves DA; Lira EC; Baviera AM; Cao P; Zanon NM; Arany Z; Bedard N; Tanksale P; Wing SS; Lecker SH; Kettelhut IC; Navegantes LC
Endocrinology; 2009 Dec; 150(12):5395-404. PubMed ID: 19837877
[TBL] [Abstract][Full Text] [Related]
8. A Key Role for Leukemia Inhibitory Factor in C26 Cancer Cachexia.
Seto DN; Kandarian SC; Jackman RW
J Biol Chem; 2015 Aug; 290(32):19976-86. PubMed ID: 26092726
[TBL] [Abstract][Full Text] [Related]
9. Stat3 activation links a C/EBPδ to myostatin pathway to stimulate loss of muscle mass.
Zhang L; Pan J; Dong Y; Tweardy DJ; Dong Y; Garibotto G; Mitch WE
Cell Metab; 2013 Sep; 18(3):368-79. PubMed ID: 24011072
[TBL] [Abstract][Full Text] [Related]
10. Role of ubiquitin-proteasome proteolysis in muscle fiber destruction in experimental chloroquine-induced myopathy.
Kimura N; Kumamoto T; Oniki T; Nomura M; Nakamura K; Abe Y; Hazama Y; Ueyama H
Muscle Nerve; 2009 Apr; 39(4):521-8. PubMed ID: 19296457
[TBL] [Abstract][Full Text] [Related]
11. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes.
Castillero E; Alamdari N; Lecker SH; Hasselgren PO
Metabolism; 2013 Oct; 62(10):1495-502. PubMed ID: 23866982
[TBL] [Abstract][Full Text] [Related]
12. Myostatin is a novel tumoral factor that induces cancer cachexia.
Lokireddy S; Wijesoma IW; Bonala S; Wei M; Sze SK; McFarlane C; Kambadur R; Sharma M
Biochem J; 2012 Aug; 446(1):23-36. PubMed ID: 22621320
[TBL] [Abstract][Full Text] [Related]
13. Muscle sparing in muscle RING finger 1 null mice: response to synthetic glucocorticoids.
Baehr LM; Furlow JD; Bodine SC
J Physiol; 2011 Oct; 589(Pt 19):4759-76. PubMed ID: 21807613
[TBL] [Abstract][Full Text] [Related]
14. Experimental hyperthyroidism in rats increases the expression of the ubiquitin ligases atrogin-1 and MuRF1 and stimulates multiple proteolytic pathways in skeletal muscle.
O'Neal P; Alamdari N; Smith I; Poylin V; Menconi M; Hasselgren PO
J Cell Biochem; 2009 Nov; 108(4):963-73. PubMed ID: 19777444
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the anticatabolic effects of leucine and Ca-β-hydroxy-β-methylbutyrate in experimental models of cancer cachexia.
Mirza KA; Pereira SL; Voss AC; Tisdale MJ
Nutrition; 2014; 30(7-8):807-13. PubMed ID: 24984997
[TBL] [Abstract][Full Text] [Related]
16. The role of E3 ubiquitin-ligases MuRF-1 and MAFbx in loss of skeletal muscle mass.
Rom O; Reznick AZ
Free Radic Biol Med; 2016 Sep; 98():218-230. PubMed ID: 26738803
[TBL] [Abstract][Full Text] [Related]
17. Absence of caspase-3 protects against denervation-induced skeletal muscle atrophy.
Plant PJ; Bain JR; Correa JE; Woo M; Batt J
J Appl Physiol (1985); 2009 Jul; 107(1):224-34. PubMed ID: 19390003
[TBL] [Abstract][Full Text] [Related]
18. RANKL Mediates Muscle Atrophy and Dysfunction in a Cigarette Smoke-induced Model of Chronic Obstructive Pulmonary Disease.
Xiong J; Le Y; Rao Y; Zhou L; Hu Y; Guo S; Sun Y
Am J Respir Cell Mol Biol; 2021 May; 64(5):617-628. PubMed ID: 33689672
[TBL] [Abstract][Full Text] [Related]
19. An extract of Artemisia dracunculus L. inhibits ubiquitin-proteasome activity and preserves skeletal muscle mass in a murine model of diabetes.
Kirk-Ballard H; Wang ZQ; Acharya P; Zhang XH; Yu Y; Kilroy G; Ribnicky D; Cefalu WT; Floyd ZE
PLoS One; 2013; 8(2):e57112. PubMed ID: 23437325
[TBL] [Abstract][Full Text] [Related]
20. Myostatin induces degradation of sarcomeric proteins through a Smad3 signaling mechanism during skeletal muscle wasting.
Lokireddy S; McFarlane C; Ge X; Zhang H; Sze SK; Sharma M; Kambadur R
Mol Endocrinol; 2011 Nov; 25(11):1936-49. PubMed ID: 21964591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
